Results 91 to 97 of about 55,188 (97)

Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma.

Journal of Clinical Oncology, 2005
T. Witzig, S. Geyer, I. Ghobrial, D. Inwards, R. Fonseca, Paul J. Kurtin, S. Ansell, R. Luyun, P. Flynn, R. Morton, S. Dakhil, H. Gross, S. Kaufmann   +12 more
semanticscholar   +1 more source

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

Investigational new drugs, 2005
Susan M. Chang, P. Wen, T. Cloughesy, H. Greenberg, D. Schiff, C. Conrad, K. Fink, H. Robins, L. Angelis, J. Raizer, K. Hess, K. Aldape, K. Lamborn, J. Kuhn, J. Dancey, M. Prados, North American Brain Tumor Consortium and the National C Institute   +16 more
semanticscholar   +1 more source

Pharmacotherapy for BPH-related LUTS: associations between medication patterns, persistence, and treatment failure

World journal of urology
Takeshi Soda, Tomohide Yamauchi, Hikari Otsuka, Noriyuki Makita, Takuya Okada   +4 more
semanticscholar   +1 more source

Intensive personal mentoring: accelerators’ secret sauce

Small Business Economics
Eyal Rechter, Gil Avnimelech
semanticscholar   +1 more source

Phase I/II trial of CCI 779 and bevacizumab in advanced renal cell carcinoma (RCC): Safety and activity in RTKI refractory RCC patients.

Journal of Clinical Oncology, 2009
J. Merchan, H. Pitot, R. Qin, G. Liu, T. Fitch, J. Picus, W. Maples, C. Erlichman   +7 more
semanticscholar   +1 more source

The effect of urgent-start peritoneal dialysis and urgent-start hemodialysis on clinical outcomes in patients with chronic kidney disease: an updated systematic review and meta-analysis

International Urology and Nephrology
Peixin Duan, Hailuo Zhang, Yun Zhang
semanticscholar   +1 more source

A Phase 1 clinical study of temsirolimus (CCI-779) in Japanese patients with advanced solid tumors.

Japanese Journal of Clinical Oncology, 2010
Y. Fujisaka, Y. Yamada, N. Yamamoto, A. Horiike, T. Tamura   +4 more
semanticscholar   +1 more source